Sci Pharm
Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells
In a 48-week Phase 2 study published in The New England Journal of Medicine, subjects receiving the highest dose of retatrutide (12 mg) showed a mean percentage change in body weight that exceeded the 24% mark
The researchers concluded that MOTS-c may serve as a promising therapeutic target for inflammatory pain.23 Bone growth MOTS-c promotes osteoblast proliferation, differentiation, and mineralization, say the authors of a 2023 review.24 Osteoblasts, by the way, are cells that both form new bones and heal existing ones the more of them you have, the stronger and denser your bones are likely to be.25 So MOTS-cs osteoblast-promoting action is great news for anyone at high risk of developing osteoporosis, such as postmenopausal women.26 Quality of life Each of the health concerns weve addressed here metabolic dysfunction,27 increased body fat,28 decreased physical capacity,29 increased inflammation,30 and reduced bone density31 often correlates with advanced age, so it follows that attenuating these factors would result in a more robust and enjoyable aging experience
Your hormone levels are fluctuating wildly on their way to a new normal
